1. 0029: Treg Cells, B7-H41 Macrophages and Their Relationship with Survival in Ovarian Cancer. (1st October 2006) Authors: Tafti, S.; Cheng, P.; Myers, L.; Kryczek, I.; Wei, S.; Chen, L.; Coukos, G.; Zou, W Journal: International journal of gynecological cancer Issue: Volume 16(2006)Supplement 3 Page Start: 607 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 11P Association of VISTA-expressing CD66b-positive neutrophils, with response and survival benefit from pembrolizumab in advanced malignant pleural mesothelioma. (December 2022) Authors: Homicsko, K.; Zygoura, P.; Tissot, S.; Norkin, M.; Popat, S.; Curioni-Fontecedro, A.; O'Brien, M.E.R.; Pope, T.; Shah, R.; Kammler, R.; Finn, S.P.; Coukos, G.; Dafni, U.; Peters, S.; Stahel, R.A. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 42P Tumor-reactive CD8+ T cells in ovarian and colon cancer in tumors and cell products. (December 2022) Authors: Bobisse, S.; Navarro Rodrigo, B.; Ngo, Q-A.; Chiffelle, J.; Genolet, R.; Michel, A.; Saugy, D.; Sauvage, C.; Tarussio, D.; Arnaud, M.; Guillaume, P.; Stevenson, B.; Bassani-Sternberg, M.; Tissot, S.; Rusakiewicz, S.; Schmidt, J.; Dangaj, D.; Kandalaft, L.; Coukos, G.; Harari, A. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 5P Tumor microenvironment cellular crosstalk predicts response to adoptive TIL therapy in melanoma patients. (December 2022) Authors: Dangaj, D.; Barras, D.; Ghisoni, E.; Chiffelle, J.; Orcurto, A.; Dagher, J.; Fahr, N.; Dafni, U.; Sempoux, C.; Michielin, O.A.; Trueb, L.; Harari, A.; Coukos, G. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. An ultra-sensitive impedimetric immunosensor for detection of the serum oncomarker CA-125 in ovarian cancer patients1. Issue 8 (28th February 2015) Authors: Johari-Ahar, M.; Rashidi, M. R.; Barar, J.; Aghaie, M.; Mohammadnejad, D.; Ramazani, A.; Karami, P.; Coukos, G.; Omidi, Y. Journal: Nanoscale Issue: Volume 7:Issue 8(2015) Page Start: 3768 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy of cancer vaccines in selected gynaecological breast and ovarian cancers: A 20-year systematic review and meta-analysis. (January 2021) Authors: Dafni, U.; Martín-Lluesma, S.; Balint, K.; Tsourti, Z.; Vervita, K.; Chenal, J.; Coukos, G.; Zaman, K.; Sarivalasis, A.; Kandalaft, L.E. Journal: European journal of cancer Issue: Volume 142(2021) Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. EP-1577: Prostate cancer SBRT dose escalation to the dominant nodule/s: Phase I and immunological effects. (April 2018) Authors: Herrera, F.; Valerio, V.; Harari, A.; Berthold, B.; Meuwly, J.Y.; Valle, V.; Coukos, G.; Jichlinski, P.; Bourhis, J. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S849 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. INTRATUMORAL T-CELLS AND SELECT TUMOR MICROENVIRONMENT SIGNIFICANTLY PREDICT CLINICAL OUTCOME IN ADVANCED OVARIAN CANCER. Issue 1 (1st March 2003) Authors: Katsaros, D.; Zhang, L.; Conejo-Garcia, J. R.; Fracchioli, S.; de la Longrais, I. A. Rigault; Puopolo, M.; Kang, E.; Massobrio, M.; Rubin, S. C.; Coukos, G. Journal: International journal of gynecological cancer Issue: Volume 13:Issue 1(2003) Supplement Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy. (May 2021) Authors: Ghisoni, E.; Wicky, A.; Bouchaab, H.; Imbimbo, M.; Delyon, J.; Gautron Moura, B.; Gérard, C.L.; Latifyan, S.; Özdemir, B.C.; Caikovski, M.; Pradervand, S.; Tavazzi, E.; Gatta, R.; Marandino, L.; Valabrega, G.; Aglietta, M.; Obeid, M.; Homicsko, K.; Mederos Alfonso, N.N.; Zimmermann, S. Journal: European journal of cancer Issue: Volume 149(2021) Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. SP-0002: Immunotherapy. (May 2017) Authors: Coukos, G. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗